Staurosporine

Hazard statements (CLP)

H340, H350

Code

Statements

H340

May cause genetic defects

2.1 Classification of the substance or mixture

2.1a Product is a: Mono-constituent substance. 2.1b

EU Classification

No. 1272/2008 Germ cell mutagenicity (Category 1B), H340 {CLP}: Carcinogenicity (Category 1B), H350 2.1c The most important adverse physiochemical, human Refer to Sections 9-12. health, and environmental effects:

2.2 Label elements

2.2a 2.2b

Contains

2S,3R,4R,6R)-3-Methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17- triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonac osa-8,10,12,14,19,21,23,25,27-nonaen-16-one. 2.2c Labeling in accordance with (EC) No. 1272/2008: . 2.2d

Hazard pictograms

GHS08 Health hazard. 2.2e

Signal word

Danger. 2.2f

Hazard statements

H340 May cause genetic defects. H350 May cause cancer. 2.2g

Precautionary statements

P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves, protective clothing, eye protection, face protection. P308+P313 If exposed or concerned: Get medical attention. P405 Store locked up. P501 Dispose of contents and container in accordance with local, national and international regulations. 2.2h Supplementary precaution statements: .

2.3 Other hazards

No additional information available. 2.3a Does the chemical meet the criteria for PBT or vPvB? Not applicable. 2.3b

Other hazards which do not result in classification

No information available.